stockrowApimeds Pharmaceuticals US, Inc. (APUS) vs Petros Pharmaceuticals, Inc. (PTPI)
- Apimeds Pharmaceuticals US, Inc. APUS 2.69 −1.47%
- Petros Pharmaceuticals, Inc. PTPI 0.00 NaN
Apimeds Pharmaceuticals US, Inc. and Petros Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Apimeds Pharmaceuticals US, Inc. is the larger, with a market value of $4.1M against $1.0M — 4.0× the size. Across the 9 metrics below, Petros Pharmaceuticals, Inc. leads on 6 and Apimeds Pharmaceuticals US, Inc. on 3.
Valuation
Profitability
| Metric | APUS | PTPI | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | — | 118.32% | 53.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | (2.45%) |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (100.13%) | (710.28%) | (0.80%) |
| Return on assets | (84.20%) | (334.15%) | (1.67%) |
| Return on invested capital | (15.96%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack